'Sputnik V effective against new COVID strain' - CEO of fund backing Russian vaccine to RT
RT, 22 Dec 2020
RT talked with Kirill Dmitriev, the CEO of the Russian Direct Investment Fund, about the new strain of the coronavirus, vaccines, and the collaboration of Gamaleya with AstraZeneca.
The RDIF funded the development of the pioneering Russian vaccine dubbed Sputnik V and is closely involved in its international marketing.
Subscribe to RT! https://www.youtube.com/channel/UCpwvZwUam-URkxB7g4USKpg?sub_confirmation=1
RT LIVE https://www.youtube.com/watch?v=IFAcqaNzNSc
Check out http://rt.com
Like us on Facebook http://www.facebook.com/RTnews
Follow us on VK https://vk.com/rt_international
Follow us on Twitter http://twitter.com/RT_com
Follow us on Instagram http://instagram.com/rt
Follow us on Soundcloud https://soundcloud.com/rttv
#RT (Russia Today) is a global #news network broadcasting from Moscow, London, Paris and Washington studios to over 100 countries. RT is the first news channel to break the 1 billion YouTube views benchmark.
The RDIF funded the development of the pioneering Russian vaccine dubbed Sputnik V and is closely involved in its international marketing.
Subscribe to RT! https://www.youtube.com/channel/UCpwvZwUam-URkxB7g4USKpg?sub_confirmation=1
RT LIVE https://www.youtube.com/watch?v=IFAcqaNzNSc
Check out http://rt.com
Like us on Facebook http://www.facebook.com/RTnews
Follow us on VK https://vk.com/rt_international
Follow us on Twitter http://twitter.com/RT_com
Follow us on Instagram http://instagram.com/rt
Follow us on Soundcloud https://soundcloud.com/rttv
#RT (Russia Today) is a global #news network broadcasting from Moscow, London, Paris and Washington studios to over 100 countries. RT is the first news channel to break the 1 billion YouTube views benchmark.
